INIS
diseases
100%
ribosides
100%
arteries
100%
nicotinamide
92%
muscles
61%
mitochondria
53%
calves
46%
people
38%
nicotinamide-adenine dinucleotide
38%
performance
30%
therapy
23%
regeneration
15%
losses
15%
mobility
15%
oxidation
15%
abundance
7%
affinity
7%
comparative evaluations
7%
clinical trials
7%
quality of life
7%
polyphenols
7%
animals
7%
precursor
7%
injuries
7%
greenland
7%
damage
7%
nitric oxide
7%
ischemia
7%
respiration
7%
grapes
7%
skin
7%
substrates
7%
vitamins
7%
Medicine and Dentistry
Arteriosclerosis Obliterans
100%
Nicotinamide Riboside
92%
Resveratrol
61%
Sirtuin1
53%
Nicotinamide Adenine Dinucleotide
38%
Skeletal Muscle
30%
Combination Therapy
23%
Muscle
23%
Deterioration
23%
Oxidative Stress
15%
Muscle Regeneration
15%
Placebo
15%
Endothelial Nitric Oxide Synthase
7%
Mitochondrial Respiration
7%
Follow up
7%
Polyphenol
7%
Vitamin
7%
Endurance
7%
Reperfusion Injury
7%
Precursor
7%
Functional Disease
7%
Quality of Life
7%
Randomized Clinical Trial
7%
Running
7%
Skin
7%
Walking
7%
Biochemistry, Genetics and Molecular Biology
Riboside
100%
Nicotinamide
92%
Resveratrol
61%
Sirtuin1
53%
Nicotinamide Adenine Dinucleotide
38%
Skeletal Muscle
30%
Muscle Regeneration
15%
Oxidative Stress
15%
Precursor
7%
Endurance
7%
Walking
7%
Mitochondrial Respiration
7%
Life
7%
Animal Models
7%
Randomized Clinical Trial
7%
Running
7%